[Edaily Reporter KIM SAE-MI ] Celltrion(068270)is projected to achieve an operating profit of over 600 billion won in the fourth quarter of this year. Having met all quarterly operating profit targets through the third quarter, the company plans to continue its earnings growth momentum in the fourth quarter as well.
In a notice to shareholders on the 19th, Celltrion stated, “We are focusing all our efforts on achieving operating profit of at least 600 billion won in the fourth quarter to fully fulfill our commitments for this year.”
Earlier this year, Celltrion set quarterly operating profit targets of 300 billion won for the first quarter, 400 billion won for the second quarter, and 500 billion won for the third quarter. The company has met these targets every quarter through the third quarter and plans to achieve an operating profit of at least 600 billion won in the fourth quarter. If it meets this fourth-quarter target, Celltrion’s annual operating profit for this year will exceed 1.8 trillion won.
To ensure these targets are met, Seo Jung-jin, Chairman of Celltrion Group, convened approximately 80 executives—including local subsidiary representatives from major global markets such as North America, Europe, Asia, and South America, as well as head office sales executives—earlier this month to personally review sales performance and earnings forecasts.
Celltrion stated, “This meeting was held in Uzbekistan, which serves as a regional hub,” adding, “Based on the review, we believe that, despite external factors such as the recent decline in exchange rates, there will be no major difficulties in achieving the fourth-quarter operating profit target at this time.”
Chairman Seo plans to personally visit major markets worldwide starting in the middle of this month to review sales performance by country and encourage the achievement of earnings targets.
The company also reaffirmed its shareholder return policy. Celltrion decided to maintain its existing principle of returning one-third of net income to shareholders through cash dividends or the cancellation of treasury stock. The specific method of return will be determined after gathering feedback from shareholders.
Furthermore, the company plans to continuously improve profitability by securing growth engines through new drug development, efficiently executing its research and development (R&D) budget, reducing manufacturing costs, and enhancing productivity. Celltrion pledged, “Through these efforts, we will firmly establish a sustainable profit growth structure, rather than relying on one-time gains.”
Celltrion emphasized, “Just as we have kept our promises over the past three quarters, Celltrion will continue to repay our stakeholders with results rather than words, and with actions that fulfill our commitments, right up until the very end of 2026,” adding, “Chairman Seo, along with the entire management team and all employees, will remain vigilant until we fully achieve our goals.”
